Point-Counterpoint: In-Office 5% Povidone-Iodine Versus Supportive Therapy for Adenoviral Conjunctivitis
Clinical Insights in Eyecare · 30.09.2024 · 2 (4)
DOI: 10.66574/001c.123817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Insights in Eyecare, online erschienen am 30.09.2024. Verfasst von Stephanie Klemencic und 4 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Klemencic, S., Lewis, A., Coyne, A. M., Bissonnette, G. A. B., & Toms, D. E. (2024). Point-Counterpoint: In-Office 5% Povidone-Iodine Versus Supportive Therapy for Adenoviral Conjunctivitis. Clinical Insights in Eyecare, 2(4). https://doi.org/10.66574/001c.123817
Vancouver
Klemencic S, Lewis A, Coyne AM, Bissonnette GAB, Toms DE. Point-Counterpoint: In-Office 5% Povidone-Iodine Versus Supportive Therapy for Adenoviral Conjunctivitis. Clinical Insights in Eyecare. 2024;2(4). doi:10.66574/001c.123817
BibTeX
@article{Klemencic2024,
author = {Klemencic, Stephanie and Lewis, April and Coyne, Alissa M. and Bissonnette, Grace A. Brown and Toms, Danielle E.},
title = {Point-Counterpoint: In-Office 5% Povidone-Iodine Versus Supportive Therapy for Adenoviral Conjunctivitis},
journal = {Clinical Insights in Eyecare},
year = {2024},
volume = {2},
number = {4},
doi = {10.66574/001c.123817}
}
EUVIMED